|
TCP11L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.789700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.005800E-04 |
| Normal-vs-Stage2 |
7.935400E-01 |
| Normal-vs-Stage3 |
4.485800E-01 |
| Normal-vs-Stage4 |
6.807600E-01 |
| Stage1-vs-Stage2 |
2.265000E-01 |
| Stage1-vs-Stage3 |
2.456300E-02 |
| Stage1-vs-Stage4 |
3.303800E-01 |
| Stage2-vs-Stage3 |
4.558800E-01 |
| Stage2-vs-Stage4 |
8.575800E-01 |
| Stage3-vs-Stage4 |
4.436200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.422000E-02 |
| Normal-vs-AfricanAmerican |
2.458800E-01 |
| Normal-vs-Asian |
7.641800E-01 |
| Caucasian-vs-AfricanAmerican |
6.283400E-01 |
| Caucasian-vs-Asian |
3.350400E-01 |
| AfricanAmerican-vs-Asian |
4.515600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.009190E-04 |
| Normal-vs-Female |
1.417150E-01 |
| Male-vs-Female |
1.233600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.349200E-01 |
| Normal-vs-Extreme_Weight |
1.94584999999581E-05 |
| Normal-vs-Obese |
6.224200E-01 |
| Normal-vs-Extreme_Obese |
1.025990E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.617900E-02 |
| Normal_Weight-vs-Obese |
8.732200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.491360E-01 |
| Extreme_Weight-vs-Obese |
5.479400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.286600E-01 |
| Obese-vs-Extreme_Obese |
8.961800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.114200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.293800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.755130E-04 |
| Normal-vs-Age(81-100Yrs) |
4.225800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.413500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.353870E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.219500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.229830E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.046400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.519400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.03499999999313E-05 |
| Normal-VS-Type2 PRCC |
1.622790E-01 |
| Normal-VS-KIRP CIMP |
1.968220E-02 |
| Normal-VS-Unclassified PRCC |
5.922400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.413600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.398800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.562000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.161720E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.339600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.576040E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.135650E-02 |
| Normal-vs-N1 |
2.017200E-01 |
| Normal-vs-N2 |
9.487000E-01 |
| N0-vs-N1 |
2.978300E-02 |
| N0-vs-N2 |
6.219000E-01 |
| N1-vs-N2 |
6.499600E-01 |
|
|
